Overview

Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia

Status:
Unknown status
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether vincristine sulfate liposome could reduce less peripheral neuropathy than vincristine sulfate,and be as effective as vincristine sulfate in adults with Naïve Acute Lymphoblastic Leukemia.
Phase:
Phase 3
Details
Lead Sponsor:
Nanjing Luye Sike Pharmaceutical Co., Ltd.
Nanjing Luye Sike Pharmaceutical Co.,Ltd.
Collaborators:
China Medical University, China
Ethics Committee of Blood Diseases Hospital
First Affiliated Hospital of Harbin Medical University
First Affiliated Hospital of Zhejiang University
Guangdong General Hospital
Guangdong Provincial People's Hospital
Nanfang Hospital of Southern Medical University
Qilu Hospital
Qilu Hospital of Shandong University
Second Affiliated Hospital of Xi'an Jiaotong University
The First Affiliated Hospital of Zhengzhou University
The Second Hospital of Hebei Medical University
West China Hospital
Xijing Hospital
Xinqiao Hospital of Chongqing
Xuzhou Medical University
Treatments:
Vincristine